佳明集團控股(01271.HK)年度純利預減約70%至80%
格隆匯5月29日丨佳明集團控股(01271.HK)發佈公告,根據本集團截至2020年3月31日止年度未經審核綜合管理賬目初步審閲及公司目前所得其他資料,集團預期本年度的純利將較上年度減少約70%至80%。
董事會認為,純利下跌主要是由於以下原因:(i)本年度重估投資物業預期將錄得公平值虧損,而上年度則錄得公平值收益;及(ii)銷售費用增加,主要源自明翹匯(一個位於青衣細山路的在建中住宅項目)銷售活動產生的廣告及營銷費用計入集團本年度的綜合損益表內,然而預售所得款項將於該項目落成後方在集團綜合損益表中反映。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.